Curaleaf (OTCMKTS:CURLF) Shares Gap Up – Here’s What Happened

Curaleaf Holdings, Inc. (OTCMKTS:CURLF) shares gapped up before the market opened on Wednesday. The stock had previously closed at $9.76, but opened at $10.15. Curaleaf shares last traded at $9.8920, with a volume of 5,535 shares changing hands.

Analyst Upgrades and Downgrades

Several equities analysts have commented on the company. Zacks Research raised Curaleaf from a “hold” rating to a “strong-buy” rating in a report on Tuesday, July 14th. Citigroup reissued a “buy” rating on shares of Curaleaf in a report on Thursday, August 6th. Finally, UBS Group set a $6.00 price objective on Curaleaf in a research report on Monday. Three investment analysts have rated the stock with a Strong Buy rating and two have given a Buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Strong Buy” and a consensus price target of $6.00.

Curaleaf Stock Down 0.3%

The company has a current ratio of 1.52, a quick ratio of 0.73 and a debt-to-equity ratio of 1.06. The business’s fifty day moving average price is $9.84 and its 200 day moving average price is $8.57. The company has a market capitalization of $2.33 billion, a P/E ratio of -76.60 and a beta of 1.55.

Curaleaf (OTCMKTS:CURLF) last posted its earnings results on Wednesday, August 5th. The company reported $0.05 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.20) by $0.25. Curaleaf had a negative net margin of 2.62% and a negative return on equity of 0.88%. The business had revenue of $340.10 million for the quarter, compared to analysts’ expectations of $332.00 million. As a group, equities research analysts predict that Curaleaf Holdings, Inc. will post 0.01 earnings per share for the current fiscal year.

Curaleaf Company Profile

Curaleaf Holdings, Inc is a cannabis company that cultivates, processes, manufactures and sells cannabis products. Through its retail dispensaries and wholesale operations, the company offers flower, pre-rolls, vaporizers, edibles, concentrates, tinctures and other cannabis-derived products for medical and adult-use markets, where permitted by law.

Curaleaf markets products under brands that include Curaleaf, Select and Grassroots. Its business is primarily focused on the United States, where it operates a network of cultivation and processing facilities, dispensaries and distribution operations across multiple state-regulated cannabis markets.